Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1997;96:3030-3041

This Article
Right arrow Full Text
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lehmann, K. G.
Right arrow Articles by Serruys, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lehmann, K. G.
Right arrow Articles by Serruys, P. W.

(Circulation. 1997;96:3030-3041.)
© 1997 American Heart Association, Inc.


Articles

Composition of Human Thrombus Assessed by Quantitative Colorimetric Angioscopic Analysis

Kenneth G. Lehmann, MD; Robert J. van Suylen, MD; Jeane Stibbe, MD; Cornelis J. Slager, MSc; Jan A. Oomen, MSc; Arthur Maas, MD; Carlo di Mario, MD, PhD; Pim deFeyter, MD, PhD; ; Patrick W. Serruys, MD, PhD

From The Thoraxcenter and Erasmus University, Rotterdam, the Netherlands, and the University of Washington School of Medicine & VA Puget Sound Health Care System, Seattle.

Correspondence to Kenneth G. Lehmann, MD, Section of Cardiology (111C), Seattle Veterans Affairs Medical Center, 1660 S Columbian Way, Seattle, WA 98108.

Background Angioscopy surpasses other diagnostic tools, such as angiography and intravascular ultrasound, in detecting arterial thrombus. This capability arises in part from the unique ability of angioscopy to assess true color during imaging. In practice, hardware-induced chromatic distortions and the subjectivity of human color perception substantially limit the theoretic potential of angioscopic color. We used a novel application of tristimulus colorimetry to quantify thrombus color to both aid in its detection and assess its composition.

Methods and Results A series of human thrombus models were constructed in vitro. Spatial homogeneity was ensured by light and electron microscopy. Quantitative colorimetric angioscopic analysis demonstrated excellent measurement reproducibility (mean difference, 0.07% to 0.17%), unaffected by illuminating light intensity (coefficient of variation, 0.21% to 3.67%). Colorimetric parameters C1 and C2 were strongly correlated (r=.99, P<.0001) with thrombus erythrocyte concentration. Principal components analysis transformed these parameters into a single value, the thrombus erythrocyte index, with little (0.06%) loss of content. Measured and predicted concentrations were similar (mean difference, 0.16 erythrocytes per 1 ng). Randomly ordered images were also subjected to visual analysis by three experienced angioscopists, with suboptimal levels of both intraobserver (mean {kappa}=0.63) and interobserver (mean {kappa}=0.48) agreement. In addition, visual ranking resulted in a Kendall rank coefficient of 0.72 to 0.76 versus a perfect 1.00 from quantitative measurement.

Conclusions Quantitative colorimetric angioscopic analysis provides a new, objective, and reproducible analytic tool for assessing angioscopic images of human thrombus. Even under ideal circumstances, experienced angioscopists do a poor job of assessing color (and therefore composition) of human thrombi. This technique can, for the first time, provide quantitative information of thrombus composition during routine diagnostic imaging.


Key Words: thrombus • diagnosis • fibrin




This article has been cited by other articles:


Home page
CirculationHome page
M. Naghavi, P. Libby, E. Falk, S. W. Casscells, S. Litovsky, J. Rumberger, J. J. Badimon, C. Stefanadis, P. Moreno, G. Pasterkamp, et al.
From Vulnerable Plaque to Vulnerable Patient: A Call for New Definitions and Risk Assessment Strategies: Part I
Circulation, October 7, 2003; 108(14): 1664 - 1672.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. B. Batchelor, K. W. Mahaffey, P. B. Berger, E. Deutsch, S. Meier, V. Hasselblad, E. T. Fry, P. S. Teirstein, A. M. Ross, C. A. Binanay, et al.
A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial
J. Am. Coll. Cardiol., November 15, 2001; 38(6): 1608 - 1613.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. J. Topol and P. W. Serruys
Frontiers in Interventional Cardiology
Circulation, October 27, 1998; 98(17): 1802 - 1820.
[Full Text] [PDF]